Статус питания больных муковисцидозом до и после трансплантации легких
https://doi.org/10.23873/2074-0506-2017-9-2-125-136
Аннотация
В обзоре освещены ключевые особенности статуса питания больных муковисцидозом, современные подходы к мониторингу и коррекции нарушений алиментарного статуса пациентов до и после трансплантации легких (ТЛ).
Об авторах
М. Ш. Хубутия
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»
Россия
Россия
академик РАН, профессор, президент НИИ скорой помощи им. Н.В. Склифосовского, Москва, Россия
М. Е. Ильинский
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»
Россия
Россия
А. А. Рык
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»
Россия
Россия
Ю. Н. Лященко
ГБУЗ «НИИ скорой помощи им. Н.В. Склифосовского ДЗМ»
Россия
Россия
Список литературы
1. Cohen-Cymberknoh M., Shoseyov D., Kerem E. Managing cystic fibrosis: strategies that increase life expectancy and improve quality of life. Am. J. Respir. Crit. Care Med. 2011;183(11):1463–1471. PMID:21330455 DOI:10.1164/rccm.201009-1478CI
2. Li L., Somerset S. Digestive system dysfunction in cystic fibrosis: challenges for nutrition therapy. Dig. Liver Dis. 2014;46(10):865–874. PMID:25053610 DOI:10.1016/j.dld.2014.06.011
3. Culhane S., George C., Pearo B., Spoede E. Malnutrition in cystic fibrosis: a review. Nutr. Clin. Pract. 2013;28(6):676–683. PMID:24170579 DOI:10.1177/0884533613507086
4. Corey M., McLaughlin F.J., Williams M., Levison H. A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto. J. Clin. Epidemiol. 1988;41(6):583–591. PMID:3260274
5. Stallings V.A., Stark L.J., Robinson K.A. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J. Am. Diet. Assoc. 2008;108(5):832–839. PMID:18442507 DOI:10.1016/j.jada.2008.02.020
6. Петрова Н.В., Гинтер Е.К. Молекулярно-генетические аспекты муковисцидоза. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 37–80.
7. Andersen D.H., Dorothy H. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathological study. Am. J. Dis. Child. 1938;56(2):344–399. DOI:10.1001/archpedi.1938.01980140114013
8. Stephenson A.L., Mannik L.A., Walsh S. et al. Longitudinal trends in nutritional status and the relation between lung function and BMI in cystic fibrosis: a population-based cohort study. Am. J. Clin. Nutr. 2013;97(4):872–877.
9. Амелина Е.Л., Гембицкая Т.Е., Черменская А.Г. Особенности муковисцидоза взрослых. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 548–575.
10. Robinson P.J., Smith A.L., Sly P.D. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Dig. Dis. Sci. 1990;35(10):1299–1304. PM-ID:2120019
11. Perano S., Rayner C.K., Couper J. et al. Cystic fibrosis related diabetes – a new perspective on the optimal management of postprandial glycemia. J. Diabetes Complicat. 2014;28(6):904–911. PMID:25060530 DOI:10.1016/j.jdiacomp.2014.06.012
12. Debray D., Kelly D., Houwen R. et al. Best practice guidance for the diagnosis and management of cystic fibrosis-associated liver disease. J. Cyst. Fibros. 2011;10(Suppl 2):S29–S36. PMID:21658639 DOI:10.1016/S1569-1993(11)60006-4
13. Каширская Н.Ю. Поражение поджелудочной железы, изменения со стороны гепатобилиарной системы у больных муковисцидозом. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 295–345.
14. Moran A., Dunitz J., Nathan B. et al. Cystic fibrosisrelated diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care. 2009;32(9):1626– 1631. PMID:19542209 DOI:10.2337/dc09-0586
15. Waugh N., Royle P., Craigie I. et al. Screening for cystic fibrosis-related diabetes: a systematic review. Health Technol. Assess. 2012;16(24):iii–iv,1–179. PMID:22572153 DOI:10.3310/hta16240
16. Moran A., Pillay K., Becker D.J. ISPAD Clinical Practice Consensus Guidelines 2014. Management of cystic fibrosis related diabetes in children and adolescents. Pediatr. Diabetes. 2014;15(Suppl 20):65–76. PMID:25182308 DOI:10.1111/pedi.12178
17. Moran A., Brunzell C., Cohen R.C. et al. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care. 2010;33(12):2697–2708. PMID:21115772 PMCID:PMC2992215 DOI:10.2337/dc10-1768
18. Colombo C., Battezzati P.M., Crosignani A. et al. Liver disease in cystic fibrosis: a prospective study on incidence, risk factors, and outcome. Hepatology. 2002;36(6):1374– 1382. PMID:12447862 DOI:10.1053/jhep.2002.37136
19. Lindblad A., Glaumann H., Strandvik B. Natural history of liver disease in cystic fibrosis. Hepatology. 1999;30(5):1151– 1158. PMID:10534335 DOI:10.1002/hep.510300527
20. Van Biervliet S., Van Biervliet J.P., Robberecht E., Christophe A. Fatty acid composition of serum phospholipids in cystic fibrosis (CF) patients with or without CF related liver disease. Clin. Chem. Lab. Med. 2010;48(12):1751– 1755. PMID:20961201 DOI:10.1515/CCLM.2010.336
21. Conway S.P., Morton A.M., Oldroyd B. et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax. 2000;55(9):798– 804. PMID:10950902
22. Gronowitz E., Lorentzon M., Ohlsson C. et al. Docosahexaenoic acid is associated with endosteal circumference in long bones in young males with cystic fibrosis. Br. J. Nutr. 2008;99(1):160– 167. PMID:17697399 DOI:10.1017/S000711450780105X
23. Yen E.H., Quinton H., Borowitz D. Better nutritional status in early childhood is associated with improved clinical outcomes and survival in patients with cystic fibrosis. J. Pediatr. 2013;162(3):530– 535. PMID:23062247 DOI:10.1016/j.jpeds.2012.08.040
24. Kerem E., Viviani L., Zolin A. et al. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry. Eur. Respir J. 2014;43(1):125–133. PMID:23598952 DOI:10.1183/09031936.00166412
25. Sinaasappel M., Stern M., Littlewood J. et al. Nutrition in patients with cystic fibrosis: a European Consensus. J. Cyst. Fibros. 2002;1(2):51–75. PM-ID:15463811
26. Smyth A.R., Bell S.C., Bojcin S. et al. European cystic fibrosis Society standards of care: best practice guidelines. J. Cyst. Fibros. 2014;13(Suppl 1):S23– S42. PMID:24856775 DOI:10.1016/j.jcf.2014.03.010
27. Turck D., Braegger C.P., Colombo C. et al. ESPEN-ESPGHAN-ECFS guidelines on nutrition care for infants, children, and adults with cystic fibrosis. Clin. Nutr. 2016;35(3):557–577. PMID:27068495 DOI:10.1016/j.clnu.2016.03.004
28. Thomson M.A., Bucolo S., Quirk P., Shepherd R.W. Measured versus predicted resting energy expenditure in infants: a need for reappraisal. J. Pediatr. 1995;126(1):21–27. PMID:7815217
29. Thomson M.A., Wilmott R.W., Wainwright C. et al. Resting energy expenditure, pulmonary inflammation, and genotype in the early course of cystic fibrosis. J. Pediatr. 1996;129(3):367–373. PMID:8804325
30. Wood L.G., Gibson P.G., Garg M.L. Circulating markers to assess nutritional therapy in cystic fibrosis. Clin. Chim. Acta. 2005;353(1–2):13–29. PMID:15698587 DOI:10.1016/j.cccn.2004.11.002
31. Cystic Fibrosis Trust. Nutritional management of cystic fibrosis. London, UK, 2002.
32. Powers S.W., Mitchell M.J., Patton S.R. et al. Mealtime behaviors in families of infants and toddlers with cystic fibrosis. J. Cyst. Fibros. 2005;4(3):175– 182. PMID:15982934 DOI:10.1016/j.jcf.2005.05.015
33. Gaskin K. J. Nutritional care in children with cystic fibrosis: are our patients becoming better? Eur. J. Clin. Nutr. 2013;67(5):558–564. PMID:23462946 DOI:10.1038/ejcn.2013.20
34. Olveira G., Olveira C., Acosta E. et al. Fatty acid supplements improve respiratory, inflammatory and nutritional parameters in adults with cystic fibrosis. Arch. Bronconeumol. 2010;46(2):70– 77. PMID:20045240 DOI:10.1016/j.arbres.2009.11.001
35. Keen C., Olin A.C., Eriksson S. et al. Supplementation with fatty acids influences the airway nitric oxide and inflammatory markers in patients with cystic fibrosis. J. Pediatr. Gastroenterol. Nutr. 2010;50(5):537–544. PMID:20639712 DOI:10.1097/MPG.0b013e3181b47967
36. Oliver C., Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst. Rev. 2013;11:CD002201. PMID:24282091 DOI:10.1002/14651858.CD002201.pub4
37. Sermet-Gaudelus I., Bianchi M.L., Garabédian M. et al. European cystic fibrosis bone mineralisation guidelines. J. Cyst. Fibros. 2011;10(Suppl 2):S16–S23. PMID:21658635 DOI:10.1016/S1569-1993(11)60004-0
38. Cystic Fibrosis Trust. Bone mineralisation in cystic fibrosis. London, UK, 2007.
39. Chinuck R., Dewar J., Baldwin D.R., Hendron E. Appetite stimulants for people with cystic fibrosis. Cochrane Database Syst Rev. 2014;7:CD008190. PMID:25064192 DOI:10.1002/14651858.CD008190.pub2
40. Bruzzese E., Raia V., Gaudiello G. et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment. Pharmacol. Ther. 2004;20(7):813–819. PMID:15379842 DOI:10.1111/j.1365-2036.2004.02174.x
41. Bruzzese E., Raia V., Spagnuolo M.I. et al. Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. Clin. Nutr. 2007;26(3):322–328. PMID:17360077 DOI:10.1016/j.clnu.2007.01.004
42. Kindstedt-Arfwidson K., Strandvik B. Food intake in patients with cystic fibrosis on an ordinary diet. Scand. J. Gastroenterol. Suppl. 1988;143:160–162. PMID:3164504
43. Smith C., Winn A., Seddon P., Ranganathan S. A fat lot of good: balance and trends in fat intake in children with cystic fibrosis. J. Cyst. Fibros. 2012;11(2):154–157. PMID:22119390 DOI:10.1016/j.jcf.2011.10.007
44. Woestenenk J.W., Castelijns S.J., van der Ent C.K., Houwen R.H. Dietary intake in children and adolescents with cystic fibrosis. Clin Nutr. 2014;33(3):528– 532. PMID: 23920501 DOI: 10.1016/j.clnu.2013.07.011
45. Cystic Fibrosis Foundation Patient Registry. Annual Data 2012. Bethesda, Maryland, 2013.
46. Steinkamp G., Demmelmair H., Rühl-Bagheri I. et al. Energy supplements rich in linoleic acid improve body weight and essential fatty acid status of cystic fibrosis patients. J. Pediatr. Gastroenterol. Nutr. 2000;31(4):418–423. PMID:11045840
47. Rettammel A.L., Marcus M.S., Farrell P.M. et al. Oral supplementation with a high-fat, high-energy product improves nutritional status and alters serum li pids in patients with cystic fibrosis. J. Am. Diet. Assoc. 1995;95(4):454–459. PMID:7699188 DOI: 10.1016/S0002-8223(95)00121-2
48. Alison J.A., Donnelly P.M., Lennon M. et al. The effect of a comprehensive, intensive inpatient treatment program on lung function and exercise capacity in patients with cystic fibrosis. Phys. Ther. 1994;74(6):583–591. PMID:8197244
49. Heijerman H.G. Chronic obstructive lung disease and respiratory muscle function: the role of nutrition and exercise training in cystic fibrosis. Respir. Med. 1993;87(Suppl. B):49–51. PMID:8234970
50. Williams S.G., Ashworth F., McAlweenie A. et al. Percutaneous endoscopic gastrostomy feeding in patients with cystic fibrosis. Gut. 1999;44(1):87–90. PMID:9862831
51. Rosenfeld M., Casey S., Pepe M., Ramsey B.W. Nutritional effects of longterm gastrostomy feedings in children with cystic fibrosis. J. Am. Diet. Assoc. 1999;99(2): 191– 194. PMID:9972186 DOI:10.1016/S0002-8223(99)00046-2
52. Allen E.D., Mick A.B., Nicol J., McCoy K.S. Prolonged parenteral nutrition for cystic fibrosis patients. Nutr. Clin. Pract.1995;10(2):73–79. PMID:7731428 DOI:10.1177/011542659501000273
53. Авдеев С.Н. Трансплантация легких при муковисцидозе. В кн.: под ред. Капранова Н.И., Каширской Н.Ю. Муковисцидоз. М.: МЕДПРАКТИКА-М, 2014: 595–611.
54. Spahr J.E., Love R.B., Francois M. et al. Lung transplantation for cystic fibrosis: current concepts and one center's experience . J. Cyst. Fibros. 2007;6(5):334–350. PMID:17418647 DOI:10.1016/j.jcf.2006.12.010
55. Stehlik J., Edwards L.B., Kucheryavaya A.Y. et al. The Registry of the International Society for Heart and Lung transplantation: 29th adult lung and heart-lung transplant report – 2012. J. Heart Lung. Transplant. 2012;31(10):1073–1086. PMID:22975095DOI:10.1016/j.healun.2012.08.002
56. Lederer D.J., Wilt J.S., D'Ovidio F. et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am. J. Respir. Crit. Care Med. 2009;180(9):887– 895. PMID:19608717 DOI:10.1164/rccm.200903-0425OC
57. Регистр больных муковисцидозом в Российской Федерации. 2011 г. Пульмонология. 2014; Прил. Режим доступа: http://mukoviscidoz.org/doc/registr/Registr_end_2011.pdf
58. Egan J.J., Woodcock A.A., Webb A.K. Management of cystic fibrosis before and after lung transplantation. J. R. Soc. Med.1997;90(Suppl 31):47–58. PMID:9204012
59. Elborn J.S., Jagoe T., Shale D.J. Metabolic and respiratory consequences of a glucose load in hypoxic patients with cystic fibrosis. Ulster Med. 1992;61(2):188– 192. PMID:1481313
60. Hirche T.O., Knoop C., Hebestreit H. et al. Practical Guidelines: Lung Transplantation in Patients with Cystic Fibrosis. Pulm. Med. 2014;2014:621342. PMID:24800072 DOI:10.1155/2014/621342
61. Tynan C., Hasse J.M. Current nutrition practices in adult lung transplantation. Nutr. Clin. Pract. 2004;19(6):587–596. PMID:16215158 DOI:10.1177/0115426504019006587
62. Kalnins D., Wilschanski M. Maintenance of nutritional status in patients with cystic fibrosis: new and emerging therapies. Drug. Des. Devel. Ther. 2012;6:151–161. PMID:22787388 DOI:10.2147/DDDT.S9258
63. Ho T., Gupta S., Brotherwood M. et al. Increased serum vitamin A and e levels after lung transplantation. Transplantation. 2011;92(5):601–606. PMID:21841542 DOI:10.1097/TP.0b013e31822790e3
64. Stephenson A., Brotherwood M., Robert R. et al. Increased vitamin A and E levels in adult cystic fibrosis patients after lung transplantation. Transplantation. 2005;79(5):613– 615. PMID:15753854
65. Hadjiliadis D., Madill J., Chaparro C. et al. Incidence and prevalence of diabetes mellitus in patients with cystic fibrosis undergoing lung transplantation before and after lung transplantation. Clinical Transplantation. 2005;19(6):773– 778. PMID:16313324 DOI:10.1111/j.1399-0012.2005.00420.x
66. Gottlieb J., Ballmann M., von Mallinckrodt C. et al. Lung transplantation in cystic fibrosis - a position paper. Pneumologie. 2009;63(8):451–460. PMID:19670104 DOI:10.1055/s-0029-1214821
67. Gilljam M., Chaparro C., Tullis E. et al. GI complications after lung transplantation in patients with cystic fibrosis. Chest. 2003;123(1):37–41. PMID:12527600
68. Atkins B.Z., Petersen R.P., Daneshmand M.A. et al. Impact of oropharyngeal dysphagia on long-term outcomes of lung transplantation. Ann. Thorac. Surg. 2010;90(5):1622–1628. PMID:20971276 DOI:10.1016/j.athoracsur.2010.06.089
69. Dellon E.S., Morgan D.R., Mohanty S.P. et al. High incidence of gastric bezoars in cystic fibrosis patients after lung transplantation. Transplantation. 2006;81(8):1141–1146. PMID:16641599 DOI:10.1097/01.tp.0000205813.54136.85
70. Mendez B.M., Davis C.S., Weber C. et al. Gastroesophageal reflux disease in lung transplant patients with cystic fibrosis. Am. J. Surg. 2012;204(5):e21– e26. PMID:22921151 DOI:10.1016/j.amjsurg.2012.07.019
71. Quon B.S., Mayer-Hamblett N., Aitken M.L., Goss C.H. Risk of post lung transplant renal dysfunction in adults with cystic fibrosis. Chest. 2012;142(1):185– 191. PMID:22222189 DOI:10.1378/chest.11-1926
72. Outbreak of Salmonella serotype Javinia infections. Orlando, Florida, June 2002. MMWR Morb Mortal Wkly Rep. 2002;51(31):683–684. PMID:12233909
73. Goulet V., Hebert M., Hedberg C. et al. Incidence of listeriosis and relate d mortality among groups at risk of acquiring listeriosis. Clin. Infect. Dis. 2012;54(5):652–660. PMID:22157172 DOI:10.1093/cid/cir902
74. Mathur S., Hornblower E., Levy R.D. Exercise training before and after lung transplantation. Phys. Sportsmed. 2009;37(3):78–87. PMID:20048531 DOI:10.3810/psm.2009.10.1732
Рецензия
Для цитирования:
Хубутия М.Ш., Ильинский М.Е., Рык А.А., Лященко Ю.Н. Статус питания больных муковисцидозом до и после трансплантации легких. Трансплантология. 2017;9(2):125-136. https://doi.org/10.23873/2074-0506-2017-9-2-125-136
For citation:
Khubutiya M.S., Il'inskiy M.E., Ryk A.A., Lyashchenko Yu.N. Nutritional status in patients with cystic fi brosis before and after lung transplantation. Transplantologiya. The Russian Journal of Transplantation. 2017;9(2):125-136. https://doi.org/10.23873/2074-0506-2017-9-2-125-136
Просмотров: 743
Послать статью по эл. почте 